Latest news with #Brachytherapy
Yahoo
04-08-2025
- Business
- Yahoo
Brachytherapy Devices Market is Growing at CAGR of 6.7% During 2025 -2031 to Reach US$534.20 Million
NEW YORK, Aug 4, 2025 /PRNewswire/ -- According to a new comprehensive report from The Insight Partners, the Brachytherapy Devices Market is witnessing significant growth due to the rising incidence of cancer worldwide and technological advancements in brachytherapy devices. The Brachytherapy Devices Market value is expected to reach US$534.20 million by 2031 from US$343.57 million in 2024; the market is anticipated to register a CAGR of 6.7% during 2025–2031. The market growth is attributed to the rising incidence of cancer worldwide, the aging population, and the technological advancements in brachytherapy devices. The Brachytherapy Devices Market analysis focuses on advancements such as MRI-compatible applicators and real-time imaging integration that play a vital role in the market growth. The report runs an in-depth analysis of market trends, key players, and future opportunities. Check valuable insights in the Brachytherapy Devices Market report. You can easily get a sample PDF of the report - Overview of Brachytherapy Devices Market Report Findings Rising Incidence of Cancer Worldwide:As per the GLOBOCAN 2020 report, more than 28.4 million new cancer cases are expected to be reported by 2040. An aging population, lack of physical activity, exposure to pollutants in the environment, and alterations in diet lead to increased rates of an internal radiation treatment, is ideal for the treatment of prostate, cervical, breast, and skin cancers. It allows for the radiation to be targeted directly to the tumor and avoid the surrounding healthy tissues, with reduced side effects and improved recovery times. Thus, brachytherapy is becoming increasingly popular among oncologists and cancer remains among the major causes of mortality globally, demand for effective, low-invasive, and affordable treatment procedures is rising. Brachytherapy is meeting this demand, particularly in facilities where it might not be possible to access highly advanced external radiation facilities. Thus, the increasing burden of cancers worldwide propels the market growth. Technological Advancements in Brachytherapy Devices:Advances in the area are improving the accuracy, safety, and effectiveness of treatments, making brachytherapy a progressively appealing choice for cancer technological advancements include the creation of high-dose rate (HDR) and low-dose rate (LDR) machines, which provide more accurate radiation delivery. HDR machines provide for administering higher doses of radiation in shorter times, making treatment faster and more convenient for patients. MRI-compatible applicators and integration of sophisticated imaging are providing better tumor localization and online monitoring of treatment. These advances allow clinicians to target tumors effectively with less exposure to healthy tissues in the proximity. The robot-assisted platforms provide higher accuracy and precision, particularly in challenging anatomical areas. In addition, miniaturization and mobility of brachytherapy equipment are facilitating treatments, especially in developing advances in technology are making brachytherapy more effective and safer but and increasing its uses in treating a broader spectrum of cancers. Consequently, the greater uptake of these machines is contributing to their adoption and setting the limits of cancer treatment even higher. Geographical Insights: In 2024, North America led the market with a substantial revenue share, followed by Europe and Asia Pacific. Asia Pacific is expected to register the highest CAGR during the forecast period. Stay Updated on Brachytherapy Devices Market Trends: Brachytherapy Devices Market Segmentation Based on product, the Brachytherapy Devices Market is segmented into seeds, brachytherapy afterloaders and applicators, and electronic brachytherapy. The brachytherapy afterloaders segment held the largest market share in 2024. In terms of type, the Brachytherapy Devices Market is categorized into high-dose rate brachytherapy implant and low-dose rate brachytherapy implant. The low-dose rate brachytherapy implant segment dominated the market in 2024. By application, the Brachytherapy Devices Market is segmented into breast cancer, cervical cancer, prostate cancer, lung cancer, and others. The prostate cancer segment dominated the market in 2024. Per end user, the Brachytherapy Devices Market is divided into hospitals and specialty clinics, ambulatory surgical centers, and others. The hospitals and specialty clinics segment dominated the market in 2024. The Brachytherapy Devices Market is segmented into five major regions: North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. Competitive Strategy and Development Key players: Elekta, Varian Medical Systems, Inc., BEBIG Medical, Theragenics Corporation, IsoAid, Siemens Healthineers AG, BXTA, BD, and Eckert and Ziegler are among the major companies operating in the Brachytherapy Devices Market. Trending topics: Advancements in Imaging Technologies, Government Initiatives and Cancer Treatment Programs, Technological Advancements in Brachytherapy Devices, Integration of Artificial Intelligence (AI) and Robotics in brachytherapy, etc. Headlines on Brachytherapy Devices Market Artemis Hospital Announces the Launch of Brachytherapy Services, Expanding Advanced Cancer Care Papua New Guinea Resumes Radiotherapy, Starts Brachytherapy Services with IAEA Support BEBIG Medical Launches SagiNova Brachytherapy System at Father Muller Hospital as a Part of New Healthcare Wing Medanta Patents MAOLO Brachytherapy Device For Advanced Cervical Cancer Treatment Elekta Expands Brachytherapy Portfolio With Acquisition of iCad Inc.'s Xoft Business CivaTech Oncology Receives FDA Approval for CivaSheet Brachytherapy Device Get Premium Copy of Brachytherapy Devices Market Size and Growth Report by 2031 at: Conclusion The growth of the Brachytherapy Devices Market is fueled by the increasing prevalence of cancer, advances in technology, and soaring demand for minimally invasive treatment options. The high-dose rate (HDR) systems, MRI-compatible applicators, and robotic-assisted devices are increasing the accuracy of treatment and speeding up patient recovery. Further, there is a growing demand for affordable and patient-centric therapies, particularly in areas that have poor access to conventional cancer therapy. With increasing uses in prostate, breast, and cervical cancers, the demand for brachytherapy is surging, with better results and accessibility in cancer therapy. The report from The Insight Partners provides several stakeholders—including manufacturers of seeds, brachytherapy afterloaders and applicators, and electronic brachytherapy devices—with valuable insights to navigate this evolving market landscape and unlock new opportunities. Trending Related Reports: Brachytherapy After Loaders Market Strategies, Top Players, Growth Opportunities, Analysis and Forecast by 2031 Cancer Therapy Market Scope, Share, and Size by 2031 Pancreatic Cancer Therapy Market SWOT Analysis by 2031 Lung Cancer Therapy Market Research Report by 2030 Cancer Biopsies Market Trends, Share, and Growth – 2031 Cervical Cancer Diagnostics and Therapeutics Market Size 2031 Kidney Cancer Therapeutics And Diagnostics Market Size 2031 Cancer Biopsies Market Trends, Share, and Growth - 2031 Thyroid Cancer Diagnostics Market Growth and Share by 2031 About Us: The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials. Contact Us:If you have any queries about this report or if you would like further information, please get in touch with us:Contact Person: Ankit MathurE-mail: +1-646-491-9876 Logo: View original content: SOURCE The Insight Partners Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Time of India
04-06-2025
- Health
- Time of India
SRN hosp to install advance machine for cancer treatment
Prayagraj: Swaroop Rani Nehru Hospital, under the Prime Minister's Health Protection Scheme (PMSSY), is set to install an HDR Brachytherapy machine for cancer treatment in the coming months. The project, initially proposed in 2016 as part of a Super Speciality Block, was temporarily shelved due to the COVID-19 pandemic, which redirected all available resources and infrastructure. According to the media in charge of SRN, Dr Santosh Kumar Singh, the medical college will soon procure the machine because the most crucial component—an underground shielded bunker required for its installation—has not been constructed. The layout is now ready, and work on the radiation-safe bunker has been initiated following communication with the state govt. Detailing what Brachytherapy is, Dr Singh said, "Brachytherapy is a highly focused type of internal radiation therapy used for cancers like cervical, prostate, breast and skin cancers. It involves placing a radioactive source directly inside or next to the tumour, thereby delivering a high dose of radiation to the cancer with minimal damage to surrounding healthy tissues." Unlike external beam radiation therapy (EBRT), brachytherapy ensures that the rest of the body is exposed to very little radiation, making it an effective and safe treatment modality. According to experts, "This form of radiation therapy is extremely useful for localised tumours, and once the machine is installed, it will benefit cancer patients across the region." Initially, in 2016, plans were approved to install this machine under PMSSY. By 2019, the Super Speciality Block was completed, but in 2020, during the peak of COVID-19, the building was repurposed into a dedicated COVID ward, postponing all other medical projects. "As of 2025, groundwork for bunker construction has restarted, and layout approvals are in place. Soon we will procure the machine, and the patients here at SRN will be able to get the state-of-the-art facility," said Dr Santosh, who is also the Associate Professor at MLN Medical College.
The Hindu
24-04-2025
- Health
- The Hindu
Minister promises to look into enhancing recurring expenses of KMCRI in Hubballi
Minister for Medical Education and Skill Development Sharanprakash Patil has said that he will take up the demand for enhancing the recurring expenses of Karnataka Medical College and Research Institute (KMCRI) with the Finance Department after verifying expenses under various heads in the past three years. Addressing a press conference in Hubballi, Dr. Patil admitted that there is pressure on KMCRI as it is the sole tertiary care unit in Kittur Karnataka catering to the healthcare needs of patients from several districts. He said that the government has already provided additional healthcare facilities at the hospital under various programmes. 'We want to ensure that every district has adequate healthcare facility and that's why it has been proposed to set up medical colleges in every district and also set up super-speciality hospitals. A government hospital will cater to the healthcare needs of the common man at affordable prices. Moreover, it is free for BPL card holders,' he said. To a query, he clarified that the entitled grants of KMCRI are being released regularly. On the issue of private practice of doctors, he said that the government has already issued a circular directing that doctors should do private practice only after 4 p.m. And, also, it has been made mandatory to register their attendance four times in a day and there will also be CCTV surveillance. 'Attendance will be checked regularly along with CCTV footage and any absenteeism will be treated seriously and penalised through cut in their salaries,' he said. 'Not responding' On the demand for establishment of an AIIMS in Raichur, the Minister said that while the issue has been raised several times, the Centre 'has not responded positively' to the proposal so far. Karnataka and Kerala are the only two States where there is no AIIMS, he said. To a query, he said that the issue of appointing a full-time director to KMCRI will be taken up soon but clarified that the acting director has all the powers of a full-time director. To another query on the lack of medicine and doctors prescribing medicine to be purchased from medical stores, he said that he will take it up during the review meeting. He clarified that writing prescriptions for outside medicine is strictly prohibited and action will be taken against in such cases. The Minister said that the government has proposed an increase of 800 undergraduate medical seats and 750 post-graduate seats for clinical courses in the government medical colleges of the State and expressed the confidence that the NMC will give its approval. Inauguration Subsequently, the Minister inaugurated the computerised laboratory, Brachytherapy (cancer therapy unit) set up at a cost of ₹2.2 crore, two modular operation theatres and a renovated outdoor stadium developed at a cost of ₹1.5 crore. Acting director of KMCRI S.F. Kammar and other senior doctors were present. He also held a review meeting later and visited the construction site of the branch of Jayadeva Institute of Cardiology which is planned to be completed in a year's time.
